RK
Rakshith Katta Ramanjaneya
About Rakshith Katta Ramanjaneya
Data last updated:
Rakshith Katta Ramanjaneya is an Additional Director at Profit Shoe Company Private Limited (since 2025), Additional Director at Pelicon Homes Private Limited (since 2025) and Director at Smo Clinical Research (India) Private Limited (since 2024), and holds 4 more current directorships. The companies operate in Consumer Goods, Real Estate and Construction and Pharma. The 4 current companies with reported revenue have a combined latest revenue of ₹67.89 Cr; the largest is Profit Shoe Company Private Limited at ₹65.34 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 10 Nov 2025 | 1995 | ₹65.34 Cr (FY 2023) | Active | |
| Additional Director | 10 Nov 2025 | 1994 | ₹1.98 Cr (FY 2023) | Active | |
| Director | 01 Mar 2024 | 2007 | ₹30.4 Lakh (FY 2025) | Active | |
| Director | 01 Mar 2024 | 2007 | ₹26.5 Lakh (FY 2025) | Active | |
| Designated Partner | 06 Jul 2026 | 2026 | Active | ||
| Additional Director | 10 Nov 2025 | 2008 | Active | ||
| Designated Partner | 02 Feb 2024 | 2024 | Active |
Board colleagues of Rakshith Katta Ramanjaneya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Padma Latha Bodepudi | 00774553 | Profit Shoe Company Private Limited , Pelicon Homes Private Limited and 1 more | Director |
| Peraiah Battineni | 01897824 | Profit Shoe Company Private Limited , Pelicon Homes Private Limited and 1 more | Director |
| Siva Koteswara Rao Bodepudi | 00774416 | Profit Shoe Company Private Limited , Pelicon Homes Private Limited and 1 more | Director |
| Teja Bodepudi | 05192710 | Profit Shoe Company Private Limited , Pelicon Homes Private Limited | Director |
| Jakkampudi Naga Sravani | 03137538 | Smo Clinical Research (India) Private Limited , Indya Clinical Research Private Limited | Director |
| Ramanjaneya Hanumanthappa Katta | 02980197 | Smo Clinical Research (India) Private Limited , Indya Clinical Research Private Limited and 1 more | Managing Director |
| Sahaja Bodepudi | 11806699 | Regalis Consulting Llp | Designated Partner |
| Rahul Katta Ramanjaneya | 10490141 | Rkr Infratech Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rakshith Katta Ramanjaneya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rakshith Katta Ramanjaneya
Rakshith Katta Ramanjaneya currently holds 7 directorships: Profit Shoe Company Private Limited (Additional Director, since 10 Nov 2025, revenue ₹65.34 Cr (FY 2023)); Pelicon Homes Private Limited (Additional Director, since 10 Nov 2025, revenue ₹1.98 Cr (FY 2023)); Smo Clinical Research (India) Private Limited (Director, since 01 Mar 2024, revenue ₹30.4 Lakh (FY 2025)); Indya Clinical Research Private Limited (Director, since 01 Mar 2024, revenue ₹26.5 Lakh (FY 2025)); Regalis Consulting Llp (Designated Partner, since 06 Jul 2026); and 2 more.
Rakshith Katta Ramanjaneya was first appointed on 02 Feb 2024 as Designated Partner at Rkr Infratech Llp. The most recent appointment on record is 06 Jul 2026 at Regalis Consulting Llp.
The 4 current companies of Rakshith Katta Ramanjaneya that report revenue have a combined latest revenue of ₹67.89 Cr: Profit Shoe Company Private Limited ₹65.34 Cr (FY 2023); Pelicon Homes Private Limited ₹1.98 Cr (FY 2023); Smo Clinical Research (India) Private Limited ₹30.4 Lakh (FY 2025); Indya Clinical Research Private Limited ₹26.5 Lakh (FY 2025).
The current boards of Rakshith Katta Ramanjaneya's companies include Padma Latha Bodepudi (Profit Shoe Company Private Limited), Peraiah Battineni (Profit Shoe Company Private Limited), Siva Koteswara Rao Bodepudi (Profit Shoe Company Private Limited), Teja Bodepudi (Profit Shoe Company Private Limited), Jakkampudi Naga Sravani (Smo Clinical Research (India) Private Limited), Ramanjaneya Hanumanthappa Katta (Smo Clinical Research (India) Private Limited), among others.